• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:

    公开号:SU965354A3
    申请号:SU802968607
    申请日:1980-08-26
    公开日:1982-10-07
    发明作者:Грэвингер Отто；Раабе Томас；Бейерле Руди；Шольтхольт Йосеф；Эберхард Нитц Рольф
    申请人:Касселла Аг (Фирма)；
    IPC主号:
    专利说明:

    To a solution of 60 ml of isopropylamine in 100 ml of ethanol is added dropwise with stirring at room temperature for 30 minutes a solution of 23 g of 1-nicotinoyl-8- (2,3-epoxyproxy-coxy) -1,2,3,4 -tetrahydroquinoline in 100 ml of ethanol. The mixture is boiled for 8 hours at reflux temperature, then the solution is concentrated under vacuum of a water-jet pump. The remaining maolo is dissolved in 100 MP of ethyl acetate and the solution is shaken twice with 30 ml of 2N hydrochloric acid. The combined hydrochloric acid extracts are adjusted to pH 11 with 2N sodium hydroxide solution and extracted twice with 50 ml of ethyl acetate. The combined ethyl acetate extracts are dried and concentrated under water jet pump vacuum. The solid residue is recrystallized from ethyl acetate, then dissolved again in ethyl acetate, and a solution of 1,5-naphthalene disulfo, a new acid in ethyl acetate, is added. The precipitated salt of 1,5-naphthalene disulfonic acid is sucked off and recrystallized twice from water. Thus, 1-nicotinoyl-8- (3-isopropylamino-2-hydroxypropoxy) -1, 2,3,4-tetrahydroquinoline naphthalene sulfonate-1, 5 is obtained in the form of a monohydrate. M.p. 292 ° C (with decomp.).
    Found,%: C 55.1; H 5.8; N 5.9; About 23.5; S 9.7.
    ,
    Calculated,%: C 55.1; H 5.5; N 6.2; O 23.7; S 9,5.
    Yield: 76% of theoretical.
    To obtain the free base, the naphthalene sulphate is dissolved in water, the aqueous solution is adjusted to pH 10.5 with dilute sodium hydroxide solution and the mixture is extracted twice with ethyl acetate. The ethyl acetate extracts are then concentrated in a water-jet vacuum and the residue is recrystallized from ethyl acetate.
    Thus, 1-nicotinoyl-8-C3-isopropylamino-2-oxyfunction) -l, 2, 3,4-tetrahydroquinoline is obtained as a free base. M.p. 1220s
    Found,%: C 68.2; H 7.5; N 11.4 O- 12.9.
    ;
     Calculated,%: C68.3; H7.3; N il, 4; About 13.0.
    The 1-NICOTINOIL-8- (2,3-epoxypropoxy) -1,2,3,4-tetrahydroquinoline used as starting material was prepared as follows.
    40 g of 1-nicotinoyl-8-hydroxy-1,2,3,4-tetrahydroquinoline is dissolved in 300 ml of dimethylformamide and then 21 g of potassium t-butylate are added with stirring. The mixture is stirred at 5 ° C for 20 minutes and then 66 g of epichlorohydrin is added dropwise at this temperature with stirring, then it is warmed to room temperature and further stirred for 20 hours. The mixture is then concentrated in a water jet vacuum. The residual oil is dissolved in water / toluene, the toluene phase is separated and washed twice with a dilute aqueous solution of caustic soda and once with water, dried and concentrated under vacuum of a water-jet pump. A solid residue remains, which can be directly converted using isopropylamine to 1-nicotinoyl-8-C3-isopropylamino-2-hydroxy-propoxy) -1,2,3,4-tetrahydroquinoline.
    The 1-nicotinoyl-8-hydroxy-1,2,3,4-tetrahydroquinoline used as the starting material can be prepared in the usual way by reacting 8-OXY-1,2,3,4-tetrahydroquinoline with nicotinic acid hydrochloride in toluene at at room temperature in the presence of triethylamine 122 ° C) „
    Example 2. 1-Benzoyl-8- (3-morpholino-2-hydroxypropoxy) -1, 2, 3,4-: tetrahydroquinoline.
    To a solution of 1.7 g of morpholine in 10 m of ethanol a solution of 5 g of 1-benol-8- (2,3-epoxypropoxy) -1,2,3,4,4-tetrahydroquinoline in 100 ml of ethanol is added dropwise at room temperature. And then heated for 2 hours at a temperature of reflux. Then concentrate in a water jet vacuum. The oil remains, which after some time hardens.
    After recrystallization from isopropanol, 1-benzoyl-8- (3-morpholino-2-hydroxypropoxy) -1,2,3,4-tetrahydroquinoline is obtained, m.p. 120C.
    Found,%: C 69.5; H 7.3; N 7.2; About 16., O.
    Chz gv 204Calculated,%: C 69.7; H 7.1; N
    7.1; About 16.2.
    Yield: 83% of theoretical.
    Example 3. 1-NICOTINO-8- (3-isopropylamino-2-hydroxypropoxy) -1, 2,3,4-tetrahydroquinoline.
    To a solution of 60 ml of isopropylamine in 100 ml of ethanol is added dropwise with stirring at room temperature for 30 minutes a solution of 26 g of 1-nicotinoyl-8- (3-chloro-2-hydroxypropoxy) -1,2,3,4 -tetrahydroquinoline in 100 ml of ethanol. The mixture is boiled for 8 hours at reflux temperature, then the solution is concentrated under vacuum of a water-jet pump. The remaining oil was dissolved in 100 ml of ethyl acetate and the solution was shaken twice with 30 ml of 2N hydrochloric acid. Combined hydrochloric acid extracts
    with 2N NaOH solution to pH 11 and extracted twice with 50 ml of ethyl acetate. The combined ethyl acetate extracts are washed several times with water, dried and concentrated in vacuo, obtained using a water jet pump. A solid residue remains, which is treated analogously to Example 1.
    Get 1-nicotinoyl-8- (3-isopropylamino-2-hydroxypropoxy) -1,2,3,4-tetrahydroquinoline naphthalene diisosulfonate-D, 5 in the form of a monohydrate. M.p. (with decomposition).
    yield: 72% of theoretical.
    Used 1 "as the source of the product 1-benzoyl-8- (2,3-epoxyP
    propoxy) -1,2,3,4-tetrahydroquinoline can be obtained as follows.
    In a solution of 3 g of sodium hydroxide in 350 ml of water is dissolved at room temperature 15 g of 1-benzoyl 5 -8-oxy-1,2,3,4-tetrahydrohonoline. Then, 6.5 g of epichlorohydrin is added dropwise at room temperature and the mixture is further stirred for 24 hours at room temperature. Then the precipitation is sucked off. The product can be reacted by contacting mor / folin with help without further purification. The compounds prepared analogously to Examples 1, 2 and 3 are listed in Table. one.
    Antiarrhythmic effect of the compounds of the proposed method is tested on anesthetized rats and. on dogs poisoned with strophanthin.
    The technique applied to anesthetized rats.
    Antagonized urethane to male rats (300-500 g) is intravenously infused while aconitin is detected at the same time as an ECG at a dose of 5 µg / kg / min. A measure of the antiarrhythmic effect is used before the occurrence of extrasystoles, ventricular tachycardias, trembling of the ventricles of the heart, up to death, doses of aconitine.
    Get listed in table. 2 data.
    table 2
    权利要求:
    Claims (1)
    [1]
    1-Nicotinoyl-8- (3-isopropylamin-2-hydroxypropoxy) A technique applied to dogs poisoned by strophanthin. Anesthetized with Nembutal, dogs are infused until the appearance of stable arrhythmias Strophanthin K (3 µg / kg / min, 4O min). After 10 minutes, the substances to be tested are administered intravenously or intradermally after the infusion has been completed. Normalization of the ECG for at least 10 minutes is assessed as a positive result. These are obtained in table. 3 data. T and l and ts az; Thus, the proposed method makes it possible to crawl new derived water tetrahydroquinoline of the general formula I, possessing valuable pharmacological properties. The invention The method of producing tetrahydroquinoline derivatives of the general formula I .... R ' s-cnc, 1 p5. He is where R is C, -C5-alkyl, unsubstituted or substituted phenyl, furi thienyl, or pyridyl; R independently of each other, C4-alkyl hydrogen or together with the az atom form pyrrblidinyl, peridinyl, morpholinyl, piperazinyl, N-methylpiperazinyl or imidaeolidinyl. or their salts, characterized in that the compound of the general formula 11 in-CO oeHjZ id "-fH" -HjHai where Z is -CH-CHj 0 he Hal is halogen; R - has the indicated values, is reacted with an amine of the general formula III, R% HR3, where R is as defined above, with the introduction of the desired product in free form or as a salt. Sources of information taken into account in the examination 1. Buhler K, Pearson D. Organic syntheses. M., Mir, 1973, Part 1,. 504,529,
    类似技术:
    公开号 | 公开日 | 专利标题
    EP0417210B1|1994-03-09|Novel o-|-hydroximic acid halides and process for preparing the same
    DD211344A5|1984-07-11|PROCESS FOR THE PREPARATION OF 6- | -PYRIDAZINONE DERIVATIVES
    US2899436A|1959-08-11|chjch
    SU965354A3|1982-10-07|Process for producing tetrahydroquinoline derivatives
    US3579524A|1971-05-18|2-aminoalkyl derivatives of phthalimidines
    US4439444A|1984-03-27|Amidobenzamides, their salts and pharmaceutical compositions containing them
    US4278796A|1981-07-14|Piperazines
    US4035367A|1977-07-12|Hydroxyalkyl-substituted-amino-quinolines
    US3314963A|1967-04-18|Azabenzocycloalkane-n-carboxamidines
    IL25510A|1970-03-22|Phenoxypropylamines,their preparation and use
    US4105771A|1978-08-08|1-Aminoalkylpiperidine derivatives
    IE44339B1|1981-10-21|Piperazine derivatives
    US3629266A|1971-12-21|3 4-dihydrocarbostyrils
    DE2640652A1|1977-03-17|3-SUBSTITUTED- | -1,2-BENZISOXAZOLE, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
    US4060621A|1977-11-29|Pyridyl alkylguanidine compounds
    SU428602A3|1974-05-15|METHOD OF OBTAINING BASIC-SUBSTITUTE DERIVATIVES 1
    CS221810B2|1983-04-29|Method of making the new isochinoline derivatives with contanets of sulphur
    DE2514334A1|1975-10-09|NEW PYRIDINE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
    US2786059A|1957-03-19|Derivatives of 2-nu-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines
    US4261998A|1981-04-14|Tetrahydro-isoquinoline derivatives
    US2870152A|1959-01-20|Unilcu
    US3965112A|1976-06-22|Imidazoline derivatives
    DE2436398A1|1975-02-20|MORPHOLINE DERIVATIVES
    KR790001667B1|1979-12-07|Process for the preparation of bis-trimethoxy benzyl piperazyno alkanes
    US3465039A|1969-09-02|Therapeutically active secondary and tertiary 1 - halogenphenyl - 2 - amino-alkanones |
    同族专利:
    公开号 | 公开日
    EP0025864A1|1981-04-01|
    NO154088C|1986-07-16|
    FI802562A|1981-03-01|
    EP0025864B1|1983-05-18|
    US4335123A|1982-06-15|
    AT3422T|1983-06-15|
    NO802435L|1981-03-02|
    PL226434A1|1981-04-24|
    CS214841B2|1982-06-25|
    DD153368A5|1982-01-06|
    IE801799L|1981-02-28|
    HU180607B|1983-03-28|
    DE2934609A1|1981-03-12|
    PH16625A|1983-12-05|
    PT71741A|1980-09-01|
    GR69863B|1982-07-19|
    IL60927D0|1980-10-26|
    PL124596B1|1983-02-28|
    DK351880A|1981-03-01|
    AU533484B2|1983-11-24|
    BG37994A3|1985-09-16|
    AU6179380A|1981-03-05|
    ZA805311B|1981-08-26|
    NZ194770A|1982-03-23|
    IL60927A|1984-04-30|
    ES494535A0|1981-08-01|
    MX6971E|1987-01-09|
    CA1154015A|1983-09-20|
    AR226705A1|1982-08-13|
    PT71741B|1981-06-15|
    DK152754C|1988-10-24|
    NO154088B|1986-04-07|
    DE3063335D1|1983-07-07|
    DK152754B|1988-05-09|
    ES8106297A1|1981-08-01|
    JPS5634668A|1981-04-06|
    IE50502B1|1986-04-30|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    FR1198123A|1958-06-02|1959-12-04|Rech S Biolog Soc D|Process for preparing aryloxy-amino-alcohols and their derivatives and products obtained by carrying out this process|
    US3056792A|1958-06-04|1962-10-02|Geschickter Fund Med Res|Unsymmetrical 1, 3-diamino-2-propanols|
    NL148312B|1965-03-10|1976-01-15|Pfizer|PROCESS FOR THE PREPARATION OF A DRUG THAT OF CERTAIN 1-quinolyl-2-ALKYLAMINOETHANOLDERIVATEN AND / OR acid addition salts CONTAINS AND USING THIS PROCESS OBTAINED SHAPED DRUGS, AND METHOD FOR PRODUCING SUCH MEDICINAL derivatives and their acid addition salts .|
    JPS5239035B2|1972-12-14|1977-10-03|
    JPS5253868A|1975-10-25|1977-04-30|Tanabe Seiyaku Co Ltd|Process for preparing aminopropanol derivative|JPH0227987B2|1982-10-05|1990-06-20|Kowa Co|
    US4843082A|1986-05-05|1989-06-27|E. R. Squibb & Sons, Inc.|1,2,3,4-tetrahydro-8-quinolinol derivatives and anti-allergic use thereof|
    DE3633977A1|1986-10-06|1988-04-07|Cassella Ag|TETRAHYDROQUINOL DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME|
    DE69026708T2|1989-10-20|1997-04-03|Otsuka Pharma Co Ltd|BENZOHETEROCYCLIC COMPOUNDS|
    US7229986B2|2000-05-16|2007-06-12|Takeda Pharmaceutical Company Ltd.|Melanin-concentrating hormone antagonist|
    AR051780A1|2004-11-29|2007-02-07|Japan Tobacco Inc|FUSIONED RING COMPOUNDS CONTAINING NITROGEN AND USING THEMSELVES|
    WO2021116487A1|2019-12-13|2021-06-17|Som Innovation Biotech, S.A.|Compounds for use in the treatment of niemann-pick c disease|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19792934609|DE2934609A1|1979-08-28|1979-08-28|TETRAHYDROCHINOLIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME.|
    [返回顶部]